Statement from Sandra C. Raymond, President and CEO of the Lupus Foundation of America
Lupus Foundation of America presents prestigious career awards during American College of Rheumatology Annual Scientific Meeting
Foundation-funded research studies highlighted at premier rheumatology meeting in Boston.
Award is the largest amount allocated to lupus since 2006
Empire State Building Glows Purple to Celebrate Lupus Foundation of America’s National Gala and to Call Attention to Need for Increased Awareness and Investment in Lupus Research
Sandra C. Raymond, President & CEO of the Lupus Foundation of America, issued the following statement in response to Eli Lilly and Company’s announcement of the results of two Phase III clinical trials of tabalumab.
The Lupus Foundation of America announced four grants that will allow lupus investigators to continue critical lupus research. Another grant will be used to develop a groundbreaking diagnostic tool for children with lupus-related kidney inflammation, or lupus nephritis.
The Lupus Foundation of America congratulates and welcomes the first 11 new research groups that have been awarded grants as part of the Accelerating Medicines Partnership in Lupus and Rheumatoid Arthritis (AMP Lupus and RA) Network.